Newly identified PBC risk loci overlap with those of other autoimmune disorders and harbour several immunologically relevant candidate genes, most notably chemokine ligand 20 (CCL20) and interleukin 12B (IL12B; Table 1). This evidence concerns the gene CCL20 and Autoimmunity.